Investors & Media

Corporate Profile

Investor Relations

Corporate Profile

Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health, and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner.

Investor Inquiries:
Media Inquiries:

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Sage Therapeutics Intra Stock Chart